Ategra Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,986
Closed -$1.57M 95
2022
Q3
$1.57M Sell
6,986
-4,675
-40% -$1.13M 0.81% 33
2022
Q2
$2.84M Sell
11,661
-34
-0.3% -$8.33K 1.45% 22
2022
Q1
$2.83M Buy
11,695
+189
+2% +$43.4K 1.24% 25
2021
Q4
$2.59M Buy
11,506
+5,178
+82% +$1.09M 1.12% 28
2021
Q3
$1.35M Buy
6,328
+4,627
+272% +$1.06M 0.64% 40
2021
Q2
$415K Hold
1,701
0.2% 79
2021
Q1
$423K Hold
1,701
0.23% 72
2020
Q4
$391K Hold
1,701
0.27% 65
2020
Q3
$432K Sell
1,701
-29
-2% -$7.18K 0.39% 57
2020
Q2
$408K Hold
1,730
0.39% 58
2020
Q1
$351K Buy
1,730
+40
+2% +$8.74K 0.41% 51
2019
Q4
$407K Hold
1,690
0.34% 55
2019
Q3
$327K Hold
1,690
0.3% 70
2019
Q2
$311K Sell
1,690
-52
-3% -$9.31K 0.29% 77
2019
Q1
$331K Buy
+1,742
New +$333K 0.32% 68

Other funds holding AMGN

Ategra Capital Management's AMGN Position: Q4 2022 in Review

Ategra Capital Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 6,986 shares — an estimated $1.57M sold.

Ategra Capital Management first reported a position in AMGN in Q1 2019 and held it in 15 quarters. The position peaked at $2.84M in Q2 2022. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Ategra Capital Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Ategra Capital Management sold 6,986 Amgen shares in Q4 2022, an estimated $1.57M.
  • Ategra Capital Management first reported a position in Amgen in Q1 2019 and held it in 15 quarters.
  • Ategra Capital Management's Amgen position peaked at $2.84M in Q2 2022.
  • 2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Ategra Capital Management's 13F filing for Q4 2022, filed 14 Feb 2025.